Abstract Background and Objectives Although many systematic reviews for the human
papillomavirus vaccines cost effectiveness have been published, they vary in perspectives …

1. Mahumud RA, Alam K, Keramat SA, Ormsby GM, Dunn J, Gow J (2020) Cost-
effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence …

Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Background No study has looked at differences of pooled estimates—such as meta-
analyses—of corresponding study documents of the same intervention. In this study, we …

Objective To assess the benefits and harms of the human papillomavirus (HPV) vaccines.
Data sources Clinical study reports obtained from the European Medicines Agency and …

AIM: Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be
effective against infection and disease. We examined whether HPV vaccination has the …

Aim To evaluate circumstances and prerequisites of cost effectiveness of human papilloma
virus (HPV) vaccination. Methods A comprehensive search of multiple electronic databases …

With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …

Abstract Background The World Health Organization recommends a 1-or 2-dose human
papillomavirus (HPV) vaccination schedule for females aged 9 to 20 years. Studies …

A critical review of cost-effectiveness analyses of HPV vaccination in males was conducted
and nine studies were identified in different countries. Due to the heterogeneity among these …